Início › Melanoma › Pensilvânia › Pittsburgh
Ensaios clínicos de Melanoma em Pittsburgh, PA
31 estudos para Melanoma estão buscando participantes em locais em Pittsburgh e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
RecrutandoFase 3
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
RecrutandoFase 3
- Allegheny Health Network, Pittsburgh
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
RecrutandoFase 2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
RecrutandoFase 3
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecrutandoFase 2
- University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RecrutandoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
RecrutandoFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecrutandoFase 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Project: Every Child for Younger Patients With Cancer
RecrutandoEstudo observacional
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Research Site, Pittsburgh
Investigating Real-Time Immunotherapy Symptoms Study
Recrutando
- UPMC Hillman Cancer Center, Pittsburgh
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
RecrutandoFase 1/2
- Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
RecrutandoFase 2
- UPMC Hillman Cancer Center, Pittsburgh
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
RecrutandoFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
RecrutandoEstudo observacional
- UPMC Hillman Cancer Center, Pittsburgh
Evaluation of Hypoxia in Primary Melanoma
RecrutandoEstudo observacional
- UPMC Hillman Cancer Center, Pittsburgh
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
RecrutandoFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RecrutandoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
Neoadjuvant Darovasertib in Primary Uveal Melanoma
RecrutandoFase 3
- UPMC Hillman Cancer Center, Pittsburgh
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
RecrutandoFase 1/2
- University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
RecrutandoFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
RecrutandoFase 2
- UPMC Hillman Cancer Center, Pittsburgh
RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
RecrutandoFase 1 inicial
- UPMC Hillman Cancer Center, Pittsburgh
A Study of VET3-TGI in Patients With Solid Tumors
RecrutandoFase 1
- UPMC- Hillman Cancer Center, Pittsburgh
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RecrutandoFase 2/3
- UPMC Hillman Cancer Center, Pittsburgh
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
RecrutandoFase 3
- UPMC Hillman Cancer Center, Pittsburgh
Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi
RecrutandoEstudo observacional
- UPMC Hillman Cancer Center, Pittsburgh
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
RecrutandoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- UPMC Hillman Cancer Center, Pittsburgh
Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer
RecrutandoFase 1/2
- University of Pittsburgh, Pittsburgh
Ensaios de Melanoma em outras cidades
- Houston, TX59 estudos
- New York City, NY38 estudos
- Los Angeles, CA34 estudos
- Nashville, TN33 estudos
- Boston, MA26 estudos
- Philadelphia, PA23 estudos
- San Francisco, CA22 estudos
- Atlanta, GA21 estudos
- Durham, NC21 estudos
- St. Louis, MO21 estudos
- Columbus, OH21 estudos
- Salt Lake City, UT21 estudos
Outros estudos em Pittsburgh
- Câncer de Pulmão de Não Pequenas Células48 estudos
- Câncer (todos os tipos)41 estudos
- Câncer de Mama39 estudos
- Câncer Colorretal32 estudos
- Câncer Metastático31 estudos
- Câncer de Ovário30 estudos
- Câncer Endometrial23 estudos
- Câncer de Pulmão23 estudos
- Câncer de Próstata23 estudos
- Acidente Vascular Cerebral22 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço22 estudos
- Depressão22 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.